tiprankstipranks
Trending News
More News >
Yantai North Andre Juice Co Ltd Class H (HK:2218)
:2218

Yantai North Andre Juice Co (2218) AI Stock Analysis

Compare
0 Followers

Top Page

HK

Yantai North Andre Juice Co

(OTC:2218)

Rating:80Outperform
Price Target:
Yantai North Andre Juice Co's strong financial performance and positive technical indicators position it as a solid investment opportunity in the non-alcoholic beverages sector. Despite the lack of recent cash flow data creating some uncertainty, the company's robust growth, profitability, and reasonable valuation make it an appealing choice. Its current market momentum further enhances its investment appeal.

Yantai North Andre Juice Co (2218) vs. iShares MSCI Hong Kong ETF (EWH)

Yantai North Andre Juice Co Business Overview & Revenue Model

Company DescriptionYantai North Andre Juice Co., Ltd. is a leading Chinese company specializing in the production and distribution of fruit and vegetable juices. The company primarily focuses on the processing and sale of apple juice concentrate, which is one of its core products. Operating within the food and beverage sector, Yantai North Andre Juice Co. is known for its extensive experience in fruit juice manufacturing and its strong presence in both domestic and international markets.
How the Company Makes MoneyYantai North Andre Juice Co. makes money through the production and sale of fruit and vegetable juice concentrates, with apple juice concentrate being a significant contributor to its revenue. The company sources raw fruits, which are processed into concentrates and sold to various clients, including beverage manufacturers, food companies, and wholesalers. Revenue streams include domestic sales within China and exports to international markets, where demand for high-quality juice concentrates remains robust. The company's earnings are also influenced by its ability to maintain cost-effective operations, secure favorable supply chain partnerships, and adhere to quality standards that meet the expectations of its global clientele.

Yantai North Andre Juice Co Financial Statement Overview

Summary
Yantai North Andre Juice Co exhibits strong financial health highlighted by impressive revenue growth and profitability, a debt-free balance sheet, and high equity levels. However, the absence of recent cash flow data creates some uncertainty regarding cash management and liquidity, slightly tempering the score.
Income Statement
85
Very Positive
Yantai North Andre Juice Co has shown impressive revenue growth and profitability. The revenue increased significantly from 2023 to 2024 by approximately 61.8%, indicating strong market demand and business expansion. The gross profit margin for 2024 stands at 24.8%, showcasing effective cost management. Meanwhile, the net profit margin of 18.4% and the EBITDA margin of 21.1% reflect the company's solid profitability and operational efficiency.
Balance Sheet
90
Very Positive
The balance sheet of Yantai North Andre Juice Co is robust, with no reported debt as of 2024, which underlines a strong financial position. The equity ratio is notably high at 95.2%, indicating substantial shareholder equity compared to total assets. The return on equity (ROE) is an impressive 9.8%, reflecting effective utilization of shareholder funds.
Cash Flow
70
Positive
While cash flow data for 2024 is limited, historical data shows strong free cash flow in prior years. However, the absence of current operating and free cash flow figures could be a concern for evaluating liquidity and cash generation capabilities.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.58B1.42B876.10M1.07B871.59M842.02M
Gross Profit373.57M351.53M289.04M213.14M179.67M201.02M
EBITDA309.28M299.59M299.04M230.63M197.59M156.99M
Net Income293.41M260.70M255.52M194.35M160.01M151.78M
Balance Sheet
Total Assets2.85B2.78B2.61B2.61B2.46B2.22B
Cash, Cash Equivalents and Short-Term Investments640.37M277.49M690.65M997.87M817.01M563.81M
Total Debt0.000.000.00130.09M100.06M0.00
Total Liabilities115.74M133.76M80.72M240.40M238.54M116.57M
Stockholders Equity2.73B2.65B2.53B2.37B2.23B2.11B
Cash Flow
Free Cash Flow-68.50M-271.55M185.29M119.31M158.39M
Operating Cash Flow92.25M-109.20M240.73M194.02M211.25M
Investing Cash Flow503.93M-52.64M572.42M
Financing Cash Flow-144.56M-144.56M-226.59M65.09M43.54M

Yantai North Andre Juice Co Technical Analysis

Technical Analysis Sentiment
Positive
Last Price18.72
Price Trends
50DMA
16.83
Positive
100DMA
13.20
Positive
200DMA
10.80
Positive
Market Momentum
MACD
0.61
Negative
RSI
64.97
Neutral
STOCH
63.76
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2218, the sentiment is Positive. The current price of 18.72 is above the 20-day moving average (MA) of 17.56, above the 50-day MA of 16.83, and above the 200-day MA of 10.80, indicating a bullish trend. The MACD of 0.61 indicates Negative momentum. The RSI at 64.97 is Neutral, neither overbought nor oversold. The STOCH value of 63.76 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:2218.

Yantai North Andre Juice Co Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$13.78B20.0511.06%1.46%68.96%22.15%
75
Outperform
$13.02B10.939.63%4.67%2.96%-4.32%
74
Outperform
HK$6.18B6.7811.61%9.41%-18.09%-15.08%
74
Outperform
€17.11B17.7419.23%1.54%12.91%5.31%
71
Outperform
HK$7.14B36.975.15%1.41%3.95%-42.81%
61
Neutral
HK$19.79B11.880.81%5.13%2.72%-47.45%
46
Neutral
HK$2.38B-5.91%0.63%0.93%17.34%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2218
Yantai North Andre Juice Co
18.72
10.25
120.96%
HK:2877
China Shineway Pharmaceutical Group Limited
8.18
0.65
8.63%
HK:1475
Nissin Foods Co., Ltd.
6.84
2.27
49.67%
HK:1223
Symphony Holdings Limited
0.80
-0.04
-4.76%
HK:1686
Sunevision Holdings Ltd.
7.25
4.53
166.54%
HK:3899
CIMC Enric Holdings
6.42
-0.63
-8.97%

Yantai North Andre Juice Co Corporate Events

Yantai North Andre Juice Co. Announces 2025 AGM and Key Resolutions
Apr 25, 2025

Yantai North Andre Juice Co., Ltd. has announced its upcoming Annual General Meeting (AGM) scheduled for May 16, 2025. The meeting will address several key resolutions, including the approval of the company’s annual reports, profit distribution plan, and the re-election or appointment of directors and supervisors. Additionally, the AGM will consider revisions to annual caps for related party transactions with DSM-Firmenich Pectin (Yantai) Co., Ltd. and Uni-President China Holdings Ltd. These decisions are expected to impact the company’s governance and operational strategies moving forward.

Yantai North Andre Juice Co. Releases 2025 Q1 Financial Report
Apr 22, 2025

Yantai North Andre Juice Co., Ltd. released its unaudited first quarterly report for 2025, covering the period ending March 31, 2025. The report, prepared in accordance with PRC Accounting Standards, highlights the company’s commitment to transparency and accuracy in its financial reporting. The board and senior management affirm the report’s truthfulness and completeness, ensuring stakeholders of the company’s reliable financial practices.

Yantai North Andre Juice Co. Announces Significant Profit Increase for Q1 2025
Apr 10, 2025

Yantai North Andre Juice Co., Ltd. has issued a positive profit alert, indicating a significant increase in net profit for the first quarter of 2025. The expected net profit attributable to shareholders ranges from RMB80.07 million to RMB90.87 million, marking a 50% to 70% increase compared to the same period last year. This growth is attributed to a substantial rise in sales volume of fruit juice concentrates due to increased customer demand. However, the figures are based on unaudited management accounts and are subject to confirmation, urging shareholders and investors to exercise caution.

Yantai North Andre Juice Co. Schedules Board Meeting for Quarterly Results
Apr 8, 2025

Yantai North Andre Juice Co., Ltd. has announced a board meeting scheduled for April 22, 2025, to review and approve the unaudited consolidated first quarterly results for the period ending March 31, 2025. This meeting is significant as it will provide insights into the company’s financial performance for the first quarter, potentially impacting stakeholders’ perceptions and the company’s market positioning.

Yantai North Andre Juice Co. Announces 2024 Annual Results
Mar 26, 2025

Yantai North Andre Juice Co., Ltd. has announced its audited results for the year ending December 31, 2024. The announcement complies with the Hong Kong Stock Exchange’s requirements and will be available for viewing on April 10, 2025. This release provides stakeholders with insights into the company’s financial performance and operational status, potentially impacting its market positioning and stakeholder interests.

Yantai North Andre Juice Co. Revises Annual Caps for Product Purchase Agreements
Mar 26, 2025

Yantai North Andre Juice Co., Ltd. announced revisions to its annual caps for ongoing connected transactions under the 2025-2027 President Product Purchase Framework Agreement and the Yitong Product Purchase Framework Agreement. The company has increased the annual cap for transactions with Uni-President China Holdings to RMB 50,000,000 and with Yitong to RMB 40,000,000, while also entering a new Solid Waste Treatment Transaction with Yitong capped at RMB 2,000,000 annually. These changes are part of strategic adjustments to enhance operational efficiency and meet regulatory requirements, impacting the company’s financial planning and stakeholder relationships.

Yantai North Andre Juice Co. Announces Board and Supervisory Changes
Mar 26, 2025

Yantai North Andre Juice Co., Ltd. has announced a series of proposed changes to its board of directors and supervisory committee, including the re-election or appointment of several directors and shareholder representative supervisors. These changes are set to take place following the expiration of the current board’s term at the annual general meeting in 2024. The proposed appointments aim to ensure continuity and strengthen the company’s governance structure, with new terms set to last until 2028. The announcement also includes the resignation of Mr. Li Yao and two shareholder representative supervisors, who have confirmed their departures without any disagreements with the board.

Yantai North Andre Juice Co. Announces Upcoming Board Meeting to Review Annual Results
Mar 13, 2025

Yantai North Andre Juice Co., Ltd. has announced a board meeting scheduled for March 26, 2025, to review and approve the audited annual results for the year ending December 31, 2024. The meeting will also consider the declaration of a final dividend, which could have implications for the company’s financial strategy and shareholder returns.

Yantai North Andre Juice Co. Exceeds Annual Cap Due to Increased Production
Mar 3, 2025

Yantai North Andre Juice Co., Ltd. announced that its actual transaction amount under the Yitong Product Purchase Framework Agreement exceeded the annual cap for 2024 by approximately RMB1,676,300. This was primarily due to increased production driven by higher overseas demand and advantageous raw fruit prices in certain regions. To address this, the company has implemented internal control measures and plans to enhance supervision and training to prevent future occurrences.

Yantai North Andre Juice Co. Cancels 7.8 Million Repurchased H Shares
Feb 13, 2025

Yantai North Andre Juice Co., Ltd. has announced the cancellation of 7,800,000 repurchased H shares, which were approximately 9.94% of the total issued H shares and 2.23% of the total share capital as of the Repurchase Mandate Date. This move decreases the company’s total and registered capital by RMB7,800,000, potentially impacting its financial structure and shareholder value.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 07, 2025